Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing
- PMID: 40428350
- PMCID: PMC12111038
- DOI: 10.3390/genes16050530
Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing
Abstract
Background/Objectives: Hypermobile Ehlers-Danlos syndrome (hEDS) is the most common subtype of Ehlers-Danlos syndromes (EDS), a heterogeneous group of hereditary connective tissue disorders. The hallmark features of hEDS include generalized joint hypermobility (GJH), soft or velvety skin, and persistent joint pain. The molecular etiology of hEDS remains unknown, and diagnosis is primarily clinical. The updated diagnostic criteria for hEDS requires the fulfillment of three criteria: (1) GJH, (2) a combination of musculoskeletal and systemic manifestations consistent with a connective tissue disorder, and (3) the exclusion of alternative diagnoses. However, the exclusion process and the role of genetic testing have not yet been fully refined. Methods: This retrospective review utilized data from the Hereditary Connective Tissue Disorders (HCTD) patient registry at the University of Miami, which includes individuals evaluated at the HCTD Clinic using a standardized internal clinical and genetic protocol. We analyzed data from 907 patients referred for hEDS evaluation between June 2019 and December 2022. Results: Among these patients, 178 met the 2017 diagnostic criteria for hEDS. Genetic testing identified an alternative or additional diagnosis in 47 of these individuals (26.4%), with clinical implications requiring distinct management strategies. Conclusions: These findings underscore the importance of criterion three-exclusion of alternative diagnoses-and highlight the critical yet underutilized role of genetic testing in the assessment of joint hypermobility. Furthermore, the results suggest that hypermobility may present a shared phenotype across a spectrum of disorders, including inflammatory diseases, monogenic syndromes, and chromosomal abnormalities.
Keywords: (hEDS); diagnosis of exclusion; diagnostic criteria; genetic testing; hypermobile Ehlers–Danlos syndrome.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.Am J Med Genet A. 2020 Mar;182(3):484-492. doi: 10.1002/ajmg.a.61459. Epub 2019 Dec 16. Am J Med Genet A. 2020. PMID: 31840928
-
Hypermobile Ehlers-Danlos Syndrome.2004 Oct 22 [updated 2024 Feb 22]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2004 Oct 22 [updated 2024 Feb 22]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301456 Free Books & Documents. Review.
-
Pediatric joint hypermobility: a diagnostic framework and narrative review.Orphanet J Rare Dis. 2023 May 4;18(1):104. doi: 10.1186/s13023-023-02717-2. Orphanet J Rare Dis. 2023. PMID: 37143135 Free PMC article. Review.
-
Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1010-1023. doi: 10.1016/j.bbadis.2018.01.005. Epub 2018 Jan 5. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29309923
-
Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.Dev Dyn. 2021 Mar;250(3):318-344. doi: 10.1002/dvdy.220. Epub 2020 Aug 17. Dev Dyn. 2021. PMID: 32629534 Free PMC article. Review.
References
-
- Ritelli M., Chiarelli N., Cinquina V., Vezzoli M., Venturini M., Colombi M. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center. Am. J. Med. Genet. Part A. 2024;194:174–194. doi: 10.1002/ajmg.a.63426. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous